The idea of autoimmune mechanisms in synucleinopathies was first proposed by the finding of antibody cross-reactivity recognizing Epstein-Barr virus and α-synuclein in PD brains [13], hinting at molecular mimicry leading to α-synuclein oligomerization in genetically susceptible individuals [14]. The gene discussed is SNCA; the disease is synucleinopathy.